Alphatec Holdings (ATEC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Saxon from Needham reiterated a Buy rating on the stock and has a $16.00 price target.
David Saxon has given his Buy rating due to a combination of factors including Alphatec Holdings’ strong financial performance and future growth prospects. The company reported revenue for the fourth quarter of 2024 that aligned with its previous announcements, and its EBITDA exceeded market expectations. Additionally, Alphatec Holdings achieved positive free cash flow during this period and anticipates maintaining a positive cash flow starting from the second quarter of 2025, despite seasonal expense variations in the first quarter.
Furthermore, the company’s growth is expected to remain robust, fueled by capturing market share, expanding its portfolio reach, and increasing traction with its EOS imaging technology. These factors contribute to a positive outlook for sustainable free cash flow profitability, reinforcing the Buy rating on the stock.
In another report released today, Roth MKM also reiterated a Buy rating on the stock with a $22.00 price target.